Acute coronary syndromes

2018; 19(12): 12-15

Acute coronary syndromes – improving outcomes in women

ALEXANDRA MURPHY, Jennifer Johns

2017; 18(8): 24-28

Secondary prevention after acute coronary syndromes: the GP’s role

SINJINI BISWAS, DION STUB, ANDREW E. AJANI

2016; 17(10): 25-28

How can we improve secondary prevention after ACS?

Tom Briffa, Clara Chow, Alexander Clark, Julie Redfern

Therapeutics clinic

2016; 17(7): 53-56

Duration of dual antiplatelet therapy after ACS: a moving target

Adam J Nelson, Matthew I Worthley

2016; 17(5): 16-20

Acute coronary syndromes in women: different presentation and poorer outcomes

Peter L Thompson, Brendan M McQuillan

2014; 15(4): 49-52

Effective ways to prevent recurrence of acute coronary syndrome

Julie Redfern, Tom Briffa, Rohina Joshi

2014; 15(3): 28-34

Medical management after control of myocardial ischaemia

Peter L Thompson, Chris Judkins, Angus G Thompson

2014; 15(2): 28-31

Risk stratification in non-ST-segment-elevation ACS

David Brieger

2014; 15(1): 12-17

STEMI – a medical emergency. An overview of management

John French

Clinical investigations from the RACP

2013; 14(5): 30-37

Is this chest pain due to myocardial ischaemia?

Simon O’Connor

Drug update

2012; 13(9): 59-60

Ticagrelor – a new player in the antiplatelet therapy field

Andrew Ajani

2012; 13(6): 16-22

Patients post myocardial infarction: tailored management improves outcomes

Peter L Thompson, Angus G Thompson

Diabetic urgencies

2012; 13(1): 54-57

Is this woman with diabetes having a heart attack?

Pat Phillips

2010; 11(12): 18-26

Acute coronary syndromes: management in 2010

William M Wilson, Andrew Ajani

Clinical investigations from the RACP

2010; 11(11): 53-60

Investigating the patient with cardiac chest pain

Jane McCrohon, Camilla Wainwright

2007; 8(5): 16-23

Non-ST-segment elevation acute coronary syndrome: a missed chance or the opportunity for effective therapy?

Con Aroney

2004; 5(4): 35-45

Myocardial infarction: improving patient outcomes

Con Aroney